Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib and Hydroxychloroquine in NRAS Melanoma
NCT03979651Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in melanoma (MM), sponsored by Hospices Civils de Lyon. Started Oct 2019; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
melanoma (MM)
Beyond the preview
Go deeper on NCT03979651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03979651.